Marshall Wace LLP Increases Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Marshall Wace LLP grew its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 33.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 1,097,714 shares of the company’s stock after acquiring an additional 276,765 shares during the period. Marshall Wace LLP’s holdings in Option Care Health were worth $25,467,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. increased its position in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after purchasing an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC grew its stake in Option Care Health by 638.5% during the 4th quarter. Sterling Capital Management LLC now owns 2,954 shares of the company’s stock worth $69,000 after purchasing an additional 2,554 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Price Performance

OPCH stock opened at $32.09 on Friday. The stock’s 50 day moving average price is $33.33 and its 200 day moving average price is $28.66. The firm has a market cap of $5.27 billion, a P/E ratio of 26.96, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Barrington Research increased their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. raised their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.